Browse related articlesQatar launches biomedical research program
Qatar: Thursday, June 12 - 2008 at 09:06
A world-class biomedical research program, the first of its kind in the Middle East, has been launched by the Qatar Foundation for Education, Science and Community Development and Weill Cornell Medical College in Qatar. The program aims to form a bio-medical research infrastructure that will develop a scientific and technical workforce for the benefit of the region at large. To achieve its goal the program will bring together institutions that have overlapping missions in medical education, research and healthcare.
Also consider reading:
- » Overdue health clinic opens its doors
- » Dubai plastic surgeon guilty of malpractice
- » Dubai unveils health strategy
- » Online medical directory launched
- » Marital tests find Aids cases
- » Emiratis donate more blood
- » AGU offers hospital management programme
- » Emaar to develop US hospitals
- » Dubai Health Authority partners with Philips
- » UAE president rejects IVF law
- ADD ARTICLE TO
-
Facebook
del.icio.us
Digg">
Jeff Florian, Senior ReporterThursday, June 12 - 2008 at 09:06 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Web Feeds